Versigent (NYSE:VGNT) Earns Overweight Rating from Analysts at Wells Fargo & Company

Stock analysts at Wells Fargo & Company assumed coverage on shares of Versigent (NYSE:VGNTGet Free Report) in a report issued on Monday,Benzinga reports. The firm set an “overweight” rating and a $35.00 price target on the stock.

Separately, Royal Bank Of Canada assumed coverage on shares of Versigent in a research note on Tuesday, March 31st. They issued a “sector perform” rating and a $28.00 price target for the company. One analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $31.50.

Check Out Our Latest Analysis on Versigent

Versigent Price Performance

Read More

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.